BNP Paribas Financial Markets
XBIT icon

BNP Paribas Financial Markets’s XBiotech XBIT Stock Holding History

BNP Paribas Financial Markets’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.8K Buy
27,164
+300
+1% +$726 ﹤0.01% 4575
2025
Q4 		$64.2K Buy
26,864
+6,254
+30% +$15.4K ﹤0.01% 4578
2025
Q3 		$54.8K Sell
20,610
-119
-0.6% -$352 ﹤0.01% 4564
2025
Q2 		$61.6K Buy
20,729
+4,416
+27% +$12.8K ﹤0.01% 4176
2025
Q1 		$52.9K Sell
16,313
-1,055
-6% -$3.64K ﹤0.01% 4272
2024
Q4 		$68.6K Sell
17,368
-22,672
-57% -$155K ﹤0.01% 4311
2024
Q3 		$310K Buy
40,040
+25,987
+185% +$171K ﹤0.01% 3062
2024
Q2 		$72.2K Buy
14,053
+1,531
+12% +$11.8K ﹤0.01% 3371
2024
Q1 		$102K Buy
12,522
+1,200
+11% +$6.88K ﹤0.01% 3429
2023
Q4 		$45.3K Buy
11,322
+500
+5% +$1.99K ﹤0.01% 3584
2023
Q3 		$44.6K Buy
10,822
+1,235
+13% +$6.18K ﹤0.01% 3486
2023
Q2 		$56.9K Buy
9,587
+8,114
+551% +$36.6K ﹤0.01% 3428
2023
Q1 		$5.08K Buy
1,473
+1,073
+268% +$4K ﹤0.01% 3580
2022
Q4 		$1.4K Sell
400
-1,626
-80% -$5.54K ﹤0.01% 3768
2022
Q3 		$7.33K Sell
2,026
-5,989
-75% -$28.2K ﹤0.01% 4210
2022
Q2 		$45.1K Sell
8,015
-3,889
-33% -$26.2K ﹤0.01% 3584
2022
Q1 		$103K Sell
11,904
-1,115
-9% -$11.2K ﹤0.01% 3353
2021
Q4 		$145K Buy
13,019
+8,409
+182% +$109K ﹤0.01% 3489
2021
Q3 		$59.7K Buy
4,610
+1,787
+63% +$28.5K ﹤0.01% 3463
2021
Q2 		$46.7K Sell
2,823
-4,131
-59% -$70.1K ﹤0.01% 3283
2021
Q1 		$119K Buy
6,954
+3,139
+82% +$58.6K ﹤0.01% 3275
2020
Q4 		$59.7K Buy
3,815
+79
+2% +$1.46K ﹤0.01% 3470
2020
Q3 		$71.3K Buy
3,736
+3,177
+568% +$54.8K ﹤0.01% 3295
2020
Q2 		$7.66K Sell
559
-5,866
-91% -$82.4K ﹤0.01% 3825
2020
Q1 		$68.2K Buy
6,425
+4,223
+192% +$68.7K ﹤0.01% 3405
2019
Q4 		$41.1K Buy
2,202
+1,333
+153% +$17.2K ﹤0.01% 3744
2019
Q3 		$9.09K Buy
869
+778
+855% +$6.34K ﹤0.01% 4170
2019
Q2 		$690 Buy
91
+36
+65% +$313 ﹤0.01% 4388
2019
Q1 		$606 Hold
55
– – ﹤0.01% 4171
2018
Q4 		$279 Hold
55
– – ﹤0.01% 4057
2018
Q3 		$175 Hold
55
– – ﹤0.01% 4376
2018
Q2 		$246 Sell
55
-4,647
-99% -$21K ﹤0.01% 4345
2018
Q1 		$25.2K Buy
4,702
+188
+4% +$866 ﹤0.01% 3859
2017
Q4 		$17.8K Buy
4,514
+2,041
+83% +$8.59K ﹤0.01% 3975
2017
Q3 		$10.8K Hold
2,473
– – ﹤0.01% 3849
2017
Q2 		$11.6K Buy
2,473
+2,406
+3,591% +$23K ﹤0.01% 3906
2017
Q1 		$1.1K Sell
67
-560
-89% -$7.33K ﹤0.01% 3675
2016
Q4 		$6.34K Sell
627
-664
-51% -$8.83K ﹤0.01% 3625
2016
Q3 		$17.4K Buy
1,291
+601
+87% +$8.82K ﹤0.01% 2970
2016
Q2 		$14.4K Buy
+690
New +$9.96K ﹤0.01% 2725
2016
Q1 		– Sell
-1,348
Closed -$14.7K – 3105
2015
Q4 		$14.7K Buy
1,348
+402
+42% +$5.13K ﹤0.01% 3354
2015
Q3 		$14.1K Buy
+946
New +$16.6K ﹤0.01% 3381

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets's XBIT Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its XBiotech (XBIT) stake by 1.1% in Q1 2026, buying an estimated $726 and bringing the position to 27,164 shares worth $63.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4575.

BNP Paribas Financial Markets first reported a position in XBIT in Q3 2015 and has held it in 42 quarters since. The position peaked at $310K in Q3 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • BNP Paribas Financial Markets held 27,164 shares of XBiotech worth $63.8K as of Q1 2026.
  • BNP Paribas Financial Markets bought 300 XBiotech shares in Q1 2026, an estimated $726.
  • XBiotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4575 holding.
  • BNP Paribas Financial Markets first reported a position in XBiotech in Q3 2015 and has held it in 42 quarters since.
  • BNP Paribas Financial Markets's XBiotech position peaked at $310K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.